Keyphrases
Randomized Trial
100%
Amyotrophic Lateral Sclerosis
100%
Ceftriaxone
100%
Tolerability
27%
Cerebrospinal Fluid
18%
Pharmacokinetics
18%
Data Monitoring
18%
Safety Monitoring
18%
Monitoring Boards
18%
Trough Level
18%
Placebo
9%
Adverse Events
9%
Neurotoxicity
9%
Glutamate
9%
Trial Registration
9%
Dose Effect
9%
Clinical Site
9%
Astrocytic
9%
Pharmacokinetic Analysis
9%
Ursodiol
9%
Efficacy Testing
9%
Linear Pharmacokinetics
9%
Glutamate Transporter EAAT2
9%
Pharmacology, Toxicology and Pharmaceutical Science
Amyotrophic Lateral Sclerosis
100%
Ceftriaxone
100%
Pharmacokinetics
36%
Tolerability
27%
Trough Level
18%
Placebo
9%
Adverse Event
9%
Glutamic Acid
9%
Excitotoxicity
9%
Ursodeoxycholic Acid
9%
Glutamate Transporter
9%
efficacy testing
9%